AGY fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Allergy Therapeutics Plc is a biotechnology company, which engages in the Research and Development of allergy treatments. The company was founded by Keith Iain Carter in 1998 and is headquartered in Worthing, the United Kingdom.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
AGY has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company